In addition, it is probably simplistic to envisage SGAs as a homogeneous class, and there may be significant differences between drugs in terms of their response profile.
← all excerpts
Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study.
1
—
—